These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2473576)

  • 21. ["Tertiary" lymphedema--procedures in lymph drainage therapy].
    Einfeldt H; Lange G
    Z Lymphol; 1989 Jul; 13(1):57-61. PubMed ID: 2475986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Denver shunt in malignant ascites].
    Van Damme H; Vaneerdeweg W; Schoofs E
    Acta Chir Belg; 1985; 85(1):43-52. PubMed ID: 2580408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical blood studies in patients with ovarian carcinoma treated with C-283. 3. Immunoelectrophoresis of serum proteins.
    Dobryszycka W; Gerber J; Jabloński K; Bec I
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):367-73. PubMed ID: 4115628
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pay more attention to the surveillance and deal with the recurrence in ovarian cancer].
    Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):657-8. PubMed ID: 14989220
    [No Abstract]   [Full Text] [Related]  

  • 28. Ovarian cancer: a focus on management of recurrent disease.
    Herzog TJ; Pothuri B
    Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
    Chi DS; Phaëton R; Miner TJ; Kardos SV; Diaz JP; Leitao MM; Gardner G; Huh J; Tew WP; Konner JA; Sonoda Y; Abu-Rustum NR; Barakat RR; Jaques DP
    Oncologist; 2009 Aug; 14(8):835-9. PubMed ID: 19684071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recurrence of malignant cilioepithelial ovarian cysts and their treatment].
    Vinokurov VL
    Vopr Onkol; 1972; 18(4):50-3. PubMed ID: 5028430
    [No Abstract]   [Full Text] [Related]  

  • 31. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
    Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E
    Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in progressive ovarian cancer.
    Anderson B
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S151-5. PubMed ID: 7530679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of recurrent ovarian cancer.
    Leitao MM; Chi DS
    Semin Oncol; 2009 Apr; 36(2):106-11. PubMed ID: 19332245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life for patients with epithelial ovarian cancer.
    Sun CC; Ramirez PT; Bodurka DC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):18-29. PubMed ID: 17183353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment of a recurrence of an ovarian granulosa cell tumor (1 case)].
    Livshits MA; Cheremnykh AA
    Vopr Onkol; 1970; 16(1):110-1. PubMed ID: 5434570
    [No Abstract]   [Full Text] [Related]  

  • 36. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of recurrent ovarian cancer.
    Bukowski RM; Ozols RF; Markman M
    Semin Oncol; 2007 Apr; 34(2 Suppl 2):S1-15. PubMed ID: 17512352
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin.
    van Ooijen B; van der Burg ME; Planting AS; Siersema PD; Wiggers T
    Surg Gynecol Obstet; 1993 May; 176(5):469-74. PubMed ID: 8480270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer.
    Deng X; Høgdall EV; Høgdall CK; Nørgaard-Pedersen B; Jørgensen M; Nielsen H; Engelholm SA
    Gynecol Oncol; 2000 Dec; 79(3):416-9. PubMed ID: 11104612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of recurrent ovarian cancer].
    Higuchi I
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Sep; 19(9):1114-8. PubMed ID: 5625661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.